Budget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options.

Azzeri, AmirahDahlui, MaznahMohamed, RosmawatiMcDonald, Scott AlexanderJaafar, HafizShabaruddin, Fatiha Hana2023-03-282023-03-282023-02-223693567510.3389/fpubh.2023.1114560http://hdl.handle.net/10029/626584enCopyright © 2023 Azzeri, Dahlui, Mohamed, McDonald, Jaafar and Shabaruddin.Malaysiabudget impact analysisdirect acting antiviraleconomic burdenhepatitis CBudget impact analysis of two treatment approaches for hepatitis C in Malaysia through the use of voluntary and compulsory licensing options.Article2296-2565Front public health 2023;11:1114560